AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
The current AstraZeneca(AZN) stock price is $159.45, with a market capitalization of 243.41B. The stock trades at a price-to-earnings (P/E) ratio of 23.29 and offers a dividend yield of 1.68%.
As of 2026-10-06, AstraZeneca(AZN) stock has fluctuated between $159.06 and $159.71. The current price stands at $159.45, placing the stock +0.2% above today's low and -0.2% off the high.
The AstraZeneca(AZN)'s current trading volume is 51.69K, compared to an average daily volume of 2.59M.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $153.41.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $153.41.
AZN News
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from pr...
Key Points AstraZeneca CEO Pascal Soriot told CNBC that Summit Therapeutics' lead drug could help power next-generation cancer combinations that could be the "f...
AstraZeneca (AZN) today announced the opening of its newest global strategic research and development center, in Kendall Square, Cambridge, Massachusetts. The n...
Analyst ratings
100%
of 9 ratingsMore AZN News
In a report released today, Sachin Jain from Bank of America Securities reiterated a Buy rating on AstraZeneca, with a price target of p16,500.00. Sachin Jain...
Summit Therapeutics (SMMT) announced the successful closing of AstraZeneca’s (AZN) strategic equity investment in Summit. The equity investment will support con...
AstraZeneca ( (GB:AZN) ) has provided an update. AstraZeneca has completed a $2 billion equity investment in Summit Therapeutics, strengthening its position in...
AstraZeneca, Daiichi Sankyo and Summit Therapeutics (SMMT) have agreed to test Datroway with ivonescimab in multiple cancers, beginning with a Phase III trial i...
Summit Therapeutics (SMMT) announced a clinical trial collaboration agreement with Daiichi Sankyo (DSNKY) and AstraZeneca (AZN) to evaluate ivonescimab, a novel...
Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) moved higher in Wednesday afternoon trading, extending gains from the previous session following a landmark $2...
AstraZeneca just locked in a price to own 12% of Summit Therapeutics that the open market refuses to match, and two clinical deadlines in 2026 will determine wh...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.